Advanced Genomics APAC

🔬 Blood in Urine? Don't Ignore the Warning Signs! 🚨 𝗛𝗲𝗺𝗮𝘁𝘂𝗿𝗶𝗮 (blood in urine) can be an early warning of various conditions, including 𝗯𝗹𝗮𝗱𝗱𝗲𝗿 𝗰𝗮𝗻𝗰𝗲𝗿—ranked 𝟱𝘁𝗵 in 𝗦𝗽𝗮𝗶𝗻 and 𝟵𝘁𝗵 𝘄𝗼𝗿𝗹𝗱𝘄𝗶𝗱𝗲, contributing to over 𝟯𝟱% of cases in 𝗔𝘀𝗶𝗮-𝗣𝗮𝗰𝗶𝗳𝗶𝗰. Early and accurate detection is key to better outcomes. Yet, traditional methods like 𝗰𝘆𝘀𝘁𝗼𝘀𝗰𝗼𝗽𝘆 are 𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 and can affect quality of life. What if a simple, non-invasive urine test could change that? At Advanced Genomics APAC, we are advancing solutions that prioritize early detection, patient comfort, and better healthcare accessibility. 🔍 Stay tuned for innovations that redefine cancer diagnostics! 💡 #AdvancedGenomicsAPAC #Nonacus #BladderCancer #PrecisionMedicine #NonInvasive #Blood #Urine #Genomics #Innovation

🔬Tried, Tested, and Proven: Why a Head of Oncology Service Chose Nonacus? 𝙍𝙚𝙖𝙙 𝙛𝙪𝙡𝙡 𝙖𝙧𝙩𝙞𝙘𝙡𝙚 𝙝𝙚𝙧𝙚 https://lnkd.in/gX8aVdUf Dr. Danny, Hon Fai So, Head of Oncology Service at Pangenia Inc. Hong Kong, shares his firsthand experience: 💡 "Nonacus is the only one that guarantees successful probe coverage. That means we save time, money, and precious samples—without compromise. Their customization options allow us to focus on cancer pathogenesis-related genes relevant to our region. That’s why we chose Nonacus." When experts demand reliability and flexibility, they turn to Nonacus. Watch the full testimonial to hear why! 🎥 #Nonacus #AdvancedGenomicsAPAC #Oncology #Cancer #Genomics #Healthcare #PrecisionMedicine #Research

Advanced Genomics APAC Team Connect in Japan 🇯🇵🔗✨ This past Valentine's Day, Advanced Genomics APAC team came together in Japan for a meaningful AGL APAC Team Connect Day, a time to strengthen our bond and refine our teamwork💪🏻 With incredible insights from Curtis Jordan, we engaged in strategic discussions and team-building activities that sharpened our collaborative mindset. Beyond the sessions, we also took time to explore Tokyo together, making great memories along the way. Here’s to stronger connections and even greater teamwork ahead! 💡 #AdvancedGenomicsAPAC #Team #Japan

👤 User Story | From Anxiety to Relief – A Pain-Free Diagnosis with GALEAS™ Bladder For Mrs. Smith, the fear of another invasive procedure was daunting. At 79, after a history of medical challenges, she faced the possibility of 𝗯𝗹𝗮𝗱𝗱𝗲𝗿 𝗰𝗮𝗻𝗰𝗲𝗿. After a 𝗰𝘆𝘀𝘁𝗼𝘀𝗰𝗼𝗽𝘆 left her with 𝗰𝗼𝗺𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀—and still 𝙣𝙤 𝙘𝙡𝙚𝙖𝙧 𝙖𝙣𝙨𝙬𝙚𝙧𝙨—her clinician introduced GALEAS™ Bladder, a simple, 𝗻𝗼𝗻-𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝘂𝗿𝗶𝗻𝗲 𝘁𝗲𝘀𝘁 for bladder cancer. 💬 ❝It is wonderful that there are now services available that avoid 𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 procedures but provide the same quality of results. I am happy to have as many of these tests as I need to, which are 𝘀𝗶𝗺𝗽𝗹𝗲 𝗮𝗻𝗱 𝗽𝗮𝗶𝗻 𝗳𝗿𝗲𝗲!❞ Within weeks, she received a 𝗻𝗲𝗴𝗮𝘁𝗶𝘃𝗲 result, ruling out bladder cancer and 𝗲𝗹𝗶𝗺𝗶𝗻𝗮𝘁𝗶𝗻𝗴 the need for further invasive procedures. GALEAS™ Bladder, she received the clarity she needed, offering a peace of mind. 🔗 𝐑𝐞𝐚𝐝 𝐡𝐞𝐫 𝐟𝐮𝐥𝐥 𝐣𝐨𝐮𝐫𝐧𝐞𝐲 𝐡𝐞𝐫𝐞 https://lnkd.in/gzNn2Kwc #AdvancedGenomicsAPAC #Nonacus #InformedGenomics #BladderCancer #Cancer #NonInvasive #Innovation #Healthcare #Genetics #Biotech

🩺 Asia’s Healthcare Systems Rank Among the Best in 2025 🌏 Data © https://lnkd.in/emY5TJP In 2025, several Asian countries ranked among the world’s top healthcare systems, with Taiwan achieving a Health Care Exp Index of 159.2 and a Health Care Index score of 86.5, followed by South Korea, Japan, and Thailand. The rankings reflect key factors that define a strong healthcare system, including the quality of medical professionals, availability of advanced technology, hospital efficiency, and cost-effectiveness. As Advanced Genomics APAC, headquartered in Taiwan, this recognition fuels our drive to pioneer the advancement and democratization of precision medicine, Through genetic-based testing, we aim to transform healthcare accessibility and innovation across the region, ensuring more personalized medical solutions to individuals. #AdvancedGenomicsAPAC #Nonacus #Healthcare #Medicine #Global #Genomics #Solutions #AsiaPacific

Driving Innovation in Collaboration: Advanced Genomics APAC Shares Groundbreaking Findings and Breakthroughs at the 𝗝𝗮𝗽𝗮𝗻𝗲𝘀𝗲 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗦𝘁𝘂𝗱𝘆 𝗼𝗳 𝗟𝗶𝗾𝘂𝗶𝗱 𝗕𝗶𝗼𝗽𝘀𝘆 𝟮𝟬𝟮𝟱 🇯🇵🧬 We were honored to participate in the 𝗝𝗮𝗽𝗮𝗻𝗲𝘀𝗲 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗦𝘁𝘂𝗱𝘆 𝗼𝗳 𝗟𝗶𝗾𝘂𝗶𝗱 𝗕𝗶𝗼𝗽𝘀𝘆 𝟮𝟬𝟮𝟱, contributing to insightful discussions on the future of genetic testing in clinical practice 🩺 At the event, our colleague, Ryo Kimura, introduced Nonacus' 𝗡𝗚𝗦 technology for 𝗯𝗹𝗮𝗱𝗱𝗲𝗿 𝗰𝗮𝗻𝗰𝗲𝗿 and shared key insights from our partners: • 𝗣𝗮𝗽𝗲𝗿𝘀 and 𝗹𝗮𝘁𝗲𝘀𝘁 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 related to 𝗚𝗔𝗟𝗘𝗔𝗦™ 𝗕𝗹𝗮𝗱𝗱𝗲𝗿 developed by Nonacus • Pangenia Inc highlighted how 𝗖𝗲𝗹𝗹𝟯™ 𝗧𝗮𝗿𝗴𝗲𝘁: 𝗖𝘂𝘀𝘁𝗼𝗺 𝗣𝗮𝗻𝗲𝗹 effectively meets their testing needs • CancerFree Biotech found 𝗚𝗔𝗟𝗘𝗔𝗦™ 𝗧𝘂𝗺𝗼𝗿: 𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗧𝘂𝗺𝗼𝗿 𝗣𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴, utilizing CTC-derived samples, delivers results aligned with traditional surgical evaluation, offering less invasive liquid biopsy alternative We are grateful for the encouraging feedback and remain dedicated to pushing the boundaries of liquid biopsy and genomic testing in the Asia-Pacific region. Looking forward to more breakthroughs ahead!🍀 #AdvancedGenomicsAPAC #Nonacus #Conference #LiquidBiopsy #NonInvasive #GeneticTesting #Innovation

🧬Hello from 𝗧𝗵𝗲 𝗚𝗔𝗟𝗘𝗔𝗦 𝗕𝗿𝗼𝘁𝗵𝗲𝗿𝘀🧬 Meet 𝗕𝗹𝗮𝗱𝘆, 𝗛𝗲𝗿𝗶, and 𝗧𝘂𝗺𝗼, your friendly companions on the journey to better health! Each one has a unique specialty, providing insights and support where it matters most❤️🩹 With the 𝗚𝗔𝗟𝗘𝗔𝗦 𝗕𝗿𝗼𝘁𝗵𝗲𝗿𝘀 by your side, you are never alone in taking charge of your health. Stay tuned as they share their knowledge and help make healthcare easier to understand! 😊 #AdvancedGenomicsAPAC #Nonacus #GALEAS #Brothers #Blady #Bladder #Tumo #Tumor #Heri #Hereditary #Cancer #Oncology #Health #Healthcare #Research #Biotech #Insights

Advanced Genomics APAC 🧬 | 𝗝𝗮𝗻𝘂𝗮𝗿𝘆 𝗕𝘂𝗹𝗹𝗲𝘁𝗶𝗻 We are excited to kick off 2025 with our very first newsletter!🎉 Catch up on the latest updates as we expand our network and work towards democratizing genetic testing across the Asia-Pacific region. From groundbreaking innovations like 𝗚𝗔𝗟𝗘𝗔𝗦™ 𝗕𝗹𝗮𝗱𝗱𝗲𝗿 to our ongoing efforts in 𝗮𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲, there is plenty to look forward to! 🌟 Stay in the loop and access our January updates now to learn more about the future of genomics. 🌐 𝙍𝙚𝙖𝙙 𝙃𝙚𝙧𝙚 https://lnkd.in/gpvTCP8Y #AdvancedGenomicsAPAC #Nonacus #Genomics #Cancer #Oncology #Healthcare #Research #Innovation #January #Updates #Bulletin #Newsletter

🌍 World Cancer Day🎗 The Global Cancer Observatory (GCO) by World Health Organization estimates that 𝗘𝗩𝗘𝗥𝗬 𝗠𝗜𝗡𝗨𝗧𝗘🚨±𝟭,𝟬𝟲𝟮 patients will receive a cancer diagnoses in 𝟮𝟬𝟮𝟱, and by 𝟮𝟬𝟰𝟬, new cancer cases worldwide are expected to 𝗶𝗻𝗰𝗿𝗲𝗮𝘀𝗲 𝗯𝘆 𝟯𝟯% 📈 The good news? 𝗘𝗮𝗿𝗹𝘆 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗰𝗮𝗻 𝗵𝗲𝗹𝗽 𝗽𝗿𝗲𝘃𝗲𝗻𝘁 𝟯𝟬-𝟱𝟬% 𝗼𝗳 𝗰𝗮𝗻𝗰𝗲𝗿𝘀. At Advanced Genomics APAC, we believe in the power of timely and sensitive oncology testing to support informed decisions in cancer care. By advancing genetic testing🧬 for oncology, we strive to contribute to a future where 𝗰𝗮𝗻𝗰𝗲𝗿 𝗶𝘀 𝗱𝗲𝘁𝗲𝗰𝘁𝗲𝗱 𝗲𝗮𝗿𝗹𝗶𝗲𝗿, 𝗺𝗮𝗻𝗮𝗴𝗲𝗱 𝗯𝗲𝘁𝘁𝗲𝗿, 𝗮𝗻𝗱—𝗼𝗻𝗲 𝗱𝗮𝘆—𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗲𝗱 𝗮𝗹𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿🌟 Awareness, action, and innovation can change lives❤️🩹 Let’s work together toward better outcomes! Get to know us and explore our innovations at aglapac.com 🌐 #AdvancedGenomicsAPAC #WorldCancerDay #CancerAwareness #EarlyDetection #Genomics #Genetics #Biotech #Healthcare #Cancer #Oncology

3 Features Redefining Simplicity with 𝗖𝗲𝗹𝗹𝟯™ 𝗫𝘁𝗿𝗮𝗰𝘁 🧪 When it comes to cell-free DNA extraction, 𝘤𝘰𝘮𝘱𝘭𝘦𝘹𝘪𝘵𝘺 𝘴𝘩𝘰𝘶𝘭𝘥 𝘯𝘦𝘷𝘦𝘳 𝘴𝘵𝘢𝘯𝘥 𝘪𝘯 𝘵𝘩𝘦 𝘸𝘢𝘺 𝘰𝘧 𝘱𝘳𝘰𝘨𝘳𝘦𝘴𝘴 The 𝗖𝗲𝗹𝗹𝟯™ 𝗫𝘁𝗿𝗮𝗰𝘁 is designed to 𝘀𝗶𝗺𝗽𝗹𝗶𝗳𝘆 workflows, enhance 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆, and deliver 𝗮𝗰𝗰𝘂𝗿𝗮𝘁𝗲 results—empowering researchers to focus on what truly matters🔬 ✅ Fast and Convenient workflow ✅ Versatile and Efficient Recovery ✅ Accurate Quantitation Without Carrier RNA 🌐Transform your cfDNA workflow and achieve reliable results with ease https://lnkd.in/geR8u7vG #AdvancedGenomicsAPAC #Nonacus #DNA #Extraction #Simple #Manual #cfDNA #Genomics #Biotech #Healthcare #Research #NGS #PCR